

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.43315977 |
| 2 | synaptic vesicle maturation (GO:0016188) | 5.06939296 |
| 3 | locomotory exploration behavior (GO:0035641) | 5.01952088 |
| 4 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.96407749 |
| 5 | pyrimidine nucleobase catabolic process (GO:0006208) | 4.81288590 |
| 6 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.73580860 |
| 7 | vocalization behavior (GO:0071625) | 4.65104131 |
| 8 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.51111353 |
| 9 | glutamate secretion (GO:0014047) | 4.48302778 |
| 10 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.36807027 |
| 11 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.36680224 |
| 12 | synaptic vesicle exocytosis (GO:0016079) | 4.35713130 |
| 13 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.22103786 |
| 14 | protein localization to synapse (GO:0035418) | 4.17876113 |
| 15 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.16209030 |
| 16 | behavioral response to nicotine (GO:0035095) | 4.08325009 |
| 17 | response to pheromone (GO:0019236) | 4.08250255 |
| 18 | neuron cell-cell adhesion (GO:0007158) | 4.01937416 |
| 19 | cellular potassium ion homeostasis (GO:0030007) | 3.96934985 |
| 20 | nucleobase catabolic process (GO:0046113) | 3.91842378 |
| 21 | neuronal action potential propagation (GO:0019227) | 3.89482537 |
| 22 | neurotransmitter secretion (GO:0007269) | 3.89071660 |
| 23 | synaptic transmission, glutamatergic (GO:0035249) | 3.86647181 |
| 24 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.85501517 |
| 25 | regulation of synaptic vesicle transport (GO:1902803) | 3.85313826 |
| 26 | exploration behavior (GO:0035640) | 3.85259395 |
| 27 | glutamate receptor signaling pathway (GO:0007215) | 3.83935581 |
| 28 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.77533042 |
| 29 | neuron-neuron synaptic transmission (GO:0007270) | 3.72372191 |
| 30 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.70590474 |
| 31 | dendritic spine morphogenesis (GO:0060997) | 3.66770379 |
| 32 | glycine transport (GO:0015816) | 3.55500895 |
| 33 | limb bud formation (GO:0060174) | 3.53922286 |
| 34 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.53705054 |
| 35 | long-term memory (GO:0007616) | 3.52966983 |
| 36 | retinal cone cell development (GO:0046549) | 3.50940144 |
| 37 | positive regulation of membrane potential (GO:0045838) | 3.49343598 |
| 38 | nonmotile primary cilium assembly (GO:0035058) | 3.48218584 |
| 39 | neurotransmitter transport (GO:0006836) | 3.47305388 |
| 40 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.47075235 |
| 41 | sodium ion export (GO:0071436) | 3.46274360 |
| 42 | gamma-aminobutyric acid transport (GO:0015812) | 3.45870604 |
| 43 | proline transport (GO:0015824) | 3.41192102 |
| 44 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.37454792 |
| 45 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.31065868 |
| 46 | retinal ganglion cell axon guidance (GO:0031290) | 3.30406877 |
| 47 | L-amino acid import (GO:0043092) | 3.29835759 |
| 48 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.29009924 |
| 49 | layer formation in cerebral cortex (GO:0021819) | 3.28879292 |
| 50 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.22498145 |
| 51 | regulation of postsynaptic membrane potential (GO:0060078) | 3.22493402 |
| 52 | protein polyglutamylation (GO:0018095) | 3.22088011 |
| 53 | somite development (GO:0061053) | 3.22055085 |
| 54 | neuron recognition (GO:0008038) | 3.21383763 |
| 55 | dendrite morphogenesis (GO:0048813) | 3.19980865 |
| 56 | synaptic vesicle endocytosis (GO:0048488) | 3.19044560 |
| 57 | regulation of neurotransmitter secretion (GO:0046928) | 3.19037885 |
| 58 | regulation of rhodopsin mediated signaling pathway (GO:0022400) | 3.16827856 |
| 59 | cerebral cortex radially oriented cell migration (GO:0021799) | 3.16827166 |
| 60 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 3.13950047 |
| 61 | rhodopsin mediated signaling pathway (GO:0016056) | 3.13758668 |
| 62 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.13505289 |
| 63 | membrane hyperpolarization (GO:0060081) | 3.12823400 |
| 64 | transmission of nerve impulse (GO:0019226) | 3.11570959 |
| 65 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.06186980 |
| 66 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.06062183 |
| 67 | startle response (GO:0001964) | 3.05484211 |
| 68 | regulation of collateral sprouting (GO:0048670) | 3.05400991 |
| 69 | regulation of vesicle fusion (GO:0031338) | 3.04728914 |
| 70 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.03540745 |
| 71 | negative regulation of astrocyte differentiation (GO:0048712) | 3.02789258 |
| 72 | response to auditory stimulus (GO:0010996) | 3.02323202 |
| 73 | cellular response to sterol (GO:0036315) | 3.02111215 |
| 74 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.01206028 |
| 75 | innervation (GO:0060384) | 3.00806157 |
| 76 | long-term synaptic potentiation (GO:0060291) | 2.99840157 |
| 77 | central nervous system projection neuron axonogenesis (GO:0021952) | 2.98463959 |
| 78 | axonal fasciculation (GO:0007413) | 2.97407693 |
| 79 | C4-dicarboxylate transport (GO:0015740) | 2.94505968 |
| 80 | postsynaptic membrane organization (GO:0001941) | 2.93302127 |
| 81 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.93055132 |
| 82 | central nervous system neuron axonogenesis (GO:0021955) | 2.93045562 |
| 83 | chemosensory behavior (GO:0007635) | 2.92388828 |
| 84 | membrane depolarization during action potential (GO:0086010) | 2.91688556 |
| 85 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.91535474 |
| 86 | regulation of neurotransmitter levels (GO:0001505) | 2.90474676 |
| 87 | detection of light stimulus involved in visual perception (GO:0050908) | 2.90334061 |
| 88 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.90334061 |
| 89 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.89718372 |
| 90 | DNA double-strand break processing (GO:0000729) | 2.89673583 |
| 91 | neural tube formation (GO:0001841) | 2.89184337 |
| 92 | regulation of neurotransmitter transport (GO:0051588) | 2.87687082 |
| 93 | response to histamine (GO:0034776) | 2.85610177 |
| 94 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 2.84658034 |
| 95 | cell migration in hindbrain (GO:0021535) | 2.83943668 |
| 96 | membrane depolarization (GO:0051899) | 2.83740499 |
| 97 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.83188889 |
| 98 | cellular response to cholesterol (GO:0071397) | 2.83070907 |
| 99 | spinal cord development (GO:0021510) | 2.82728349 |
| 100 | behavioral defense response (GO:0002209) | 2.82381695 |
| 101 | behavioral fear response (GO:0001662) | 2.82381695 |
| 102 | regulation of synaptic plasticity (GO:0048167) | 2.82280038 |
| 103 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.82234275 |
| 104 | righting reflex (GO:0060013) | 2.81516140 |
| 105 | neuromuscular process controlling posture (GO:0050884) | 2.80933075 |
| 106 | potassium ion homeostasis (GO:0055075) | 2.79792813 |
| 107 | auditory behavior (GO:0031223) | 2.79642396 |
| 108 | presynaptic membrane assembly (GO:0097105) | 2.79313788 |
| 109 | neuronal ion channel clustering (GO:0045161) | 2.77969069 |
| 110 | regulation of synapse structural plasticity (GO:0051823) | 2.76961060 |
| 111 | protein localization to cilium (GO:0061512) | 2.76762078 |
| 112 | epithelial cilium movement (GO:0003351) | 2.76401260 |
| 113 | cilium morphogenesis (GO:0060271) | 2.75787277 |
| 114 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.74252469 |
| 115 | cell communication by electrical coupling (GO:0010644) | 2.74072505 |
| 116 | potassium ion import (GO:0010107) | 2.73304070 |
| 117 | synaptic transmission (GO:0007268) | 2.72623686 |
| 118 | appendage development (GO:0048736) | 2.72439955 |
| 119 | limb development (GO:0060173) | 2.72439955 |
| 120 | presynaptic membrane organization (GO:0097090) | 2.72225947 |
| 121 | synapse assembly (GO:0007416) | 2.72036352 |
| 122 | positive regulation of neurotransmitter transport (GO:0051590) | 2.71441149 |
| 123 | adult walking behavior (GO:0007628) | 2.70852355 |
| 124 | cerebellar granule cell differentiation (GO:0021707) | 2.70110284 |
| 125 | cilium organization (GO:0044782) | 2.68168261 |
| 126 | fucose catabolic process (GO:0019317) | 2.67882787 |
| 127 | L-fucose metabolic process (GO:0042354) | 2.67882787 |
| 128 | L-fucose catabolic process (GO:0042355) | 2.67882787 |
| 129 | regulation of ARF protein signal transduction (GO:0032012) | 2.67325427 |
| 130 | fear response (GO:0042596) | 2.66839372 |
| 131 | cilium assembly (GO:0042384) | 2.66784605 |
| 132 | cell proliferation in forebrain (GO:0021846) | 2.66727576 |
| 133 | learning (GO:0007612) | 2.66032430 |
| 134 | neuronal action potential (GO:0019228) | 2.65532173 |
| 135 | establishment of nucleus localization (GO:0040023) | 2.65031390 |
| 136 | intraciliary transport (GO:0042073) | 2.64870770 |
| 137 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.62752241 |
| 138 | mechanosensory behavior (GO:0007638) | 2.62681359 |
| 139 | axon ensheathment in central nervous system (GO:0032291) | 2.62427683 |
| 140 | central nervous system myelination (GO:0022010) | 2.62427683 |
| 141 | regulation of respiratory system process (GO:0044065) | 2.60597489 |
| 142 | olfactory bulb development (GO:0021772) | 2.59901865 |
| 143 | regulation of neurotransmitter uptake (GO:0051580) | 2.59628443 |
| 144 | axoneme assembly (GO:0035082) | 2.59056412 |
| 145 | photoreceptor cell development (GO:0042461) | 2.58739660 |
| 146 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.58658764 |
| 147 | regulation of timing of cell differentiation (GO:0048505) | 2.57304738 |
| 148 | regulation of action potential (GO:0098900) | 2.56834864 |
| 149 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.55783398 |
| 150 | behavioral response to ethanol (GO:0048149) | 2.55662706 |
| 151 | negative regulation of axon guidance (GO:1902668) | 2.54808293 |
| 152 | inner ear receptor stereocilium organization (GO:0060122) | 2.54366012 |
| 153 | forebrain neuron differentiation (GO:0021879) | 2.51568900 |
| 154 | negative regulation of transcription regulatory region DNA binding (GO:2000678) | 2.51540030 |
| 155 | regulation of development, heterochronic (GO:0040034) | 2.49561827 |
| 156 | cilium movement (GO:0003341) | 2.48081941 |
| 157 | cAMP catabolic process (GO:0006198) | 2.47092182 |
| 158 | platelet dense granule organization (GO:0060155) | 2.46765055 |
| 159 | negative regulation of axon extension involved in axon guidance (GO:0048843) | 2.44283611 |
| 160 | regulation of mesoderm development (GO:2000380) | 2.44143826 |
| 161 | retina layer formation (GO:0010842) | 2.44092449 |
| 162 | cerebral cortex cell migration (GO:0021795) | 2.43480149 |
| 163 | indolalkylamine metabolic process (GO:0006586) | 2.42192474 |
| 164 | tachykinin receptor signaling pathway (GO:0007217) | 2.42120352 |
| 165 | detection of mechanical stimulus involved in sensory perception (GO:0050974) | 2.41582411 |
| 166 | atrial cardiac muscle cell action potential (GO:0086014) | 2.40613926 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.76654926 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.65926114 |
| 3 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.80925462 |
| 4 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.72504773 |
| 5 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.66537620 |
| 6 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.64659916 |
| 7 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.53842832 |
| 8 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.51379016 |
| 9 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.38762937 |
| 10 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.38762937 |
| 11 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.36178921 |
| 12 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.32810924 |
| 13 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.32538556 |
| 14 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.27682074 |
| 15 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.26581580 |
| 16 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.18105076 |
| 17 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.17634856 |
| 18 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.16764945 |
| 19 | FUS_26573619_Chip-Seq_HEK293_Human | 2.13867712 |
| 20 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.12434978 |
| 21 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.11979927 |
| 22 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.08840947 |
| 23 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.08540462 |
| 24 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.06771456 |
| 25 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.03683101 |
| 26 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.03588128 |
| 27 | EWS_26573619_Chip-Seq_HEK293_Human | 2.00895689 |
| 28 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.00302960 |
| 29 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.97313395 |
| 30 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.88767807 |
| 31 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.85531554 |
| 32 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.83386822 |
| 33 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.81012858 |
| 34 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.78461318 |
| 35 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.73208583 |
| 36 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.72552706 |
| 37 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.71810305 |
| 38 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.71419922 |
| 39 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.67899870 |
| 40 | * PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.66145954 |
| 41 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.65070091 |
| 42 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.58467599 |
| 43 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.54821813 |
| 44 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.51004179 |
| 45 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.48416498 |
| 46 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.46828941 |
| 47 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.45984100 |
| 48 | P300_19829295_ChIP-Seq_ESCs_Human | 1.45965785 |
| 49 | * MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.43724699 |
| 50 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.42087940 |
| 51 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.41475778 |
| 52 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.41475778 |
| 53 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.35951954 |
| 54 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.35338888 |
| 55 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.35107247 |
| 56 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.33664164 |
| 57 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.32549954 |
| 58 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.32087604 |
| 59 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.31939221 |
| 60 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.29534603 |
| 61 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.29278234 |
| 62 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.28951415 |
| 63 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.27523976 |
| 64 | AR_19668381_ChIP-Seq_PC3_Human | 1.27011544 |
| 65 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.26681406 |
| 66 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.26535921 |
| 67 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.24272784 |
| 68 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.23920599 |
| 69 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.23809597 |
| 70 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.23588341 |
| 71 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.23412847 |
| 72 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.22711472 |
| 73 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.21873051 |
| 74 | AR_25329375_ChIP-Seq_VCAP_Human | 1.21244140 |
| 75 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.20185658 |
| 76 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.20123282 |
| 77 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.20055785 |
| 78 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.19701669 |
| 79 | * TCF4_22108803_ChIP-Seq_LS180_Human | 1.19355525 |
| 80 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.19319996 |
| 81 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.19289253 |
| 82 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.19101654 |
| 83 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.18920640 |
| 84 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.18884368 |
| 85 | TCF4_23295773_ChIP-Seq_U87_Human | 1.17423722 |
| 86 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.17377777 |
| 87 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.17297204 |
| 88 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.17172697 |
| 89 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.17123890 |
| 90 | VDR_22108803_ChIP-Seq_LS180_Human | 1.16449029 |
| 91 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.16275683 |
| 92 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.15223747 |
| 93 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.13443593 |
| 94 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.13306404 |
| 95 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.13117474 |
| 96 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.12439272 |
| 97 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.11903241 |
| 98 | * SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.11598112 |
| 99 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.11178194 |
| 100 | * YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.10818771 |
| 101 | * PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.10780411 |
| 102 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.10715482 |
| 103 | * KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.10335566 |
| 104 | KDM2B_26808549_Chip-Seq_REH_Human | 1.09537841 |
| 105 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.09190640 |
| 106 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.09190640 |
| 107 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.08799306 |
| 108 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.07960601 |
| 109 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.07438805 |
| 110 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.07438805 |
| 111 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.07018042 |
| 112 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.06667689 |
| 113 | * SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.06591850 |
| 114 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.06301765 |
| 115 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.06264010 |
| 116 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.04755441 |
| 117 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.03769122 |
| 118 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.02754258 |
| 119 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.02461760 |
| 120 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.01449947 |
| 121 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 1.00726616 |
| 122 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.00505142 |
| 123 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.99453878 |
| 124 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.98440880 |
| 125 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.97986975 |
| 126 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.96140198 |
| 127 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.94509750 |
| 128 | RXR_22108803_ChIP-Seq_LS180_Human | 0.93840483 |
| 129 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.93505876 |
| 130 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.92197204 |
| 131 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.91646396 |
| 132 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.90645764 |
| 133 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.90270467 |
| 134 | * LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.89915607 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 5.69851971 |
| 2 | MP0003880_abnormal_central_pattern | 4.06066387 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 3.68439692 |
| 4 | MP0005423_abnormal_somatic_nervous | 3.57178442 |
| 5 | MP0009046_muscle_twitch | 3.22219217 |
| 6 | MP0004270_analgesia | 3.17447905 |
| 7 | MP0001968_abnormal_touch/_nociception | 3.10313002 |
| 8 | MP0009745_abnormal_behavioral_response | 3.07567502 |
| 9 | MP0002063_abnormal_learning/memory/cond | 2.91503150 |
| 10 | MP0002064_seizures | 2.89066599 |
| 11 | MP0001486_abnormal_startle_reflex | 2.63800209 |
| 12 | MP0005551_abnormal_eye_electrophysiolog | 2.60565439 |
| 13 | MP0002735_abnormal_chemical_nociception | 2.59302202 |
| 14 | MP0002572_abnormal_emotion/affect_behav | 2.56931999 |
| 15 | MP0002734_abnormal_mechanical_nocicepti | 2.51778515 |
| 16 | MP0002272_abnormal_nervous_system | 2.46702174 |
| 17 | MP0002736_abnormal_nociception_after | 2.40465685 |
| 18 | MP0002067_abnormal_sensory_capabilities | 2.25968382 |
| 19 | MP0001501_abnormal_sleep_pattern | 2.03957426 |
| 20 | MP0000778_abnormal_nervous_system | 2.02892378 |
| 21 | MP0008569_lethality_at_weaning | 1.97186665 |
| 22 | MP0005646_abnormal_pituitary_gland | 1.94125234 |
| 23 | MP0001440_abnormal_grooming_behavior | 1.93338968 |
| 24 | MP0002184_abnormal_innervation | 1.91319322 |
| 25 | MP0003136_yellow_coat_color | 1.90409971 |
| 26 | MP0003787_abnormal_imprinting | 1.89215294 |
| 27 | MP0001529_abnormal_vocalization | 1.88258775 |
| 28 | MP0004742_abnormal_vestibular_system | 1.86228409 |
| 29 | MP0001970_abnormal_pain_threshold | 1.84535967 |
| 30 | MP0002557_abnormal_social/conspecific_i | 1.83341338 |
| 31 | MP0008877_abnormal_DNA_methylation | 1.81988188 |
| 32 | MP0006276_abnormal_autonomic_nervous | 1.77348620 |
| 33 | MP0002733_abnormal_thermal_nociception | 1.75410164 |
| 34 | MP0005253_abnormal_eye_physiology | 1.73975532 |
| 35 | MP0004885_abnormal_endolymph | 1.72659055 |
| 36 | MP0006072_abnormal_retinal_apoptosis | 1.68931802 |
| 37 | MP0005645_abnormal_hypothalamus_physiol | 1.66957837 |
| 38 | MP0003879_abnormal_hair_cell | 1.59150647 |
| 39 | MP0002882_abnormal_neuron_morphology | 1.59035442 |
| 40 | MP0004858_abnormal_nervous_system | 1.57867594 |
| 41 | MP0004811_abnormal_neuron_physiology | 1.57686837 |
| 42 | MP0000569_abnormal_digit_pigmentation | 1.56639099 |
| 43 | MP0004924_abnormal_behavior | 1.55926535 |
| 44 | MP0005386_behavior/neurological_phenoty | 1.55926535 |
| 45 | MP0004142_abnormal_muscle_tone | 1.55346194 |
| 46 | MP0004043_abnormal_pH_regulation | 1.49966801 |
| 47 | MP0003119_abnormal_digestive_system | 1.44173141 |
| 48 | MP0009780_abnormal_chondrocyte_physiolo | 1.44121287 |
| 49 | MP0008789_abnormal_olfactory_epithelium | 1.43990618 |
| 50 | MP0000955_abnormal_spinal_cord | 1.42804182 |
| 51 | MP0001502_abnormal_circadian_rhythm | 1.40919020 |
| 52 | MP0005171_absent_coat_pigmentation | 1.38948749 |
| 53 | MP0002229_neurodegeneration | 1.38439531 |
| 54 | MP0002066_abnormal_motor_capabilities/c | 1.36135784 |
| 55 | MP0003890_abnormal_embryonic-extraembry | 1.35032191 |
| 56 | MP0003121_genomic_imprinting | 1.34577939 |
| 57 | MP0005187_abnormal_penis_morphology | 1.28471867 |
| 58 | MP0002234_abnormal_pharynx_morphology | 1.27910230 |
| 59 | MP0004133_heterotaxia | 1.27244337 |
| 60 | MP0002638_abnormal_pupillary_reflex | 1.25872956 |
| 61 | MP0008961_abnormal_basal_metabolism | 1.25840908 |
| 62 | MP0002751_abnormal_autonomic_nervous | 1.24580681 |
| 63 | MP0003122_maternal_imprinting | 1.23374562 |
| 64 | MP0001963_abnormal_hearing_physiology | 1.22959072 |
| 65 | MP0001984_abnormal_olfaction | 1.22519412 |
| 66 | MP0001188_hyperpigmentation | 1.21402768 |
| 67 | MP0003195_calcinosis | 1.20977164 |
| 68 | MP0002938_white_spotting | 1.19549544 |
| 69 | MP0000049_abnormal_middle_ear | 1.19027414 |
| 70 | MP0002752_abnormal_somatic_nervous | 1.17207725 |
| 71 | MP0003633_abnormal_nervous_system | 1.15980372 |
| 72 | MP0002822_catalepsy | 1.15199884 |
| 73 | MP0005409_darkened_coat_color | 1.14243156 |
| 74 | MP0002928_abnormal_bile_duct | 1.12427356 |
| 75 | MP0001986_abnormal_taste_sensitivity | 1.09679341 |
| 76 | MP0002152_abnormal_brain_morphology | 1.09262184 |
| 77 | MP0002102_abnormal_ear_morphology | 1.07994734 |
| 78 | MP0000427_abnormal_hair_cycle | 1.05036192 |
| 79 | MP0003937_abnormal_limbs/digits/tail_de | 1.04971010 |
| 80 | MP0002909_abnormal_adrenal_gland | 1.04637811 |
| 81 | MP0000516_abnormal_urinary_system | 1.00041210 |
| 82 | MP0005367_renal/urinary_system_phenotyp | 1.00041210 |
| 83 | MP0001905_abnormal_dopamine_level | 0.97396661 |
| 84 | MP0005174_abnormal_tail_pigmentation | 0.97025164 |
| 85 | MP0004147_increased_porphyrin_level | 0.96803979 |
| 86 | MP0001765_abnormal_ion_homeostasis | 0.96192399 |
| 87 | MP0005394_taste/olfaction_phenotype | 0.95553257 |
| 88 | MP0005499_abnormal_olfactory_system | 0.95553257 |
| 89 | MP0002069_abnormal_eating/drinking_beha | 0.94167442 |
| 90 | MP0000631_abnormal_neuroendocrine_gland | 0.93647117 |
| 91 | MP0003631_nervous_system_phenotype | 0.92113846 |
| 92 | MP0001485_abnormal_pinna_reflex | 0.91971870 |
| 93 | MP0000026_abnormal_inner_ear | 0.90863630 |
| 94 | MP0003938_abnormal_ear_development | 0.89994094 |
| 95 | MP0002837_dystrophic_cardiac_calcinosis | 0.88696342 |
| 96 | MP0003634_abnormal_glial_cell | 0.88679243 |
| 97 | MP0000372_irregular_coat_pigmentation | 0.88005188 |
| 98 | MP0003329_amyloid_beta_deposits | 0.87971357 |
| 99 | MP0006292_abnormal_olfactory_placode | 0.87775290 |
| 100 | MP0003878_abnormal_ear_physiology | 0.87537889 |
| 101 | MP0005377_hearing/vestibular/ear_phenot | 0.87537889 |
| 102 | MP0000647_abnormal_sebaceous_gland | 0.87243842 |
| 103 | MP0000383_abnormal_hair_follicle | 0.86465855 |
| 104 | MP0005195_abnormal_posterior_eye | 0.86241919 |
| 105 | MP0005248_abnormal_Harderian_gland | 0.84337494 |
| 106 | MP0010386_abnormal_urinary_bladder | 0.84313490 |
| 107 | MP0005084_abnormal_gallbladder_morpholo | 0.80903426 |
| 108 | MP0000920_abnormal_myelination | 0.79742068 |
| 109 | MP0002233_abnormal_nose_morphology | 0.79046499 |
| 110 | MP0005535_abnormal_body_temperature | 0.78090953 |
| 111 | MP0008872_abnormal_physiological_respon | 0.77322349 |
| 112 | MP0004145_abnormal_muscle_electrophysio | 0.76311781 |
| 113 | MP0002876_abnormal_thyroid_physiology | 0.72672889 |
| 114 | MP0003283_abnormal_digestive_organ | 0.70773909 |
| 115 | MP0001177_atelectasis | 0.68694850 |
| 116 | MP0003011_delayed_dark_adaptation | 0.67375882 |
| 117 | MP0008874_decreased_physiological_sensi | 0.63672156 |
| 118 | MP0003861_abnormal_nervous_system | 0.63080942 |
| 119 | MP0010769_abnormal_survival | 0.61387141 |
| 120 | MP0005391_vision/eye_phenotype | 0.61262991 |
| 121 | MP0004510_myositis | 0.60790642 |
| 122 | MP0005310_abnormal_salivary_gland | 0.60462839 |
| 123 | MP0010770_preweaning_lethality | 0.59570011 |
| 124 | MP0002082_postnatal_lethality | 0.59570011 |
| 125 | MP0010768_mortality/aging | 0.57877049 |
| 126 | MP0003045_fibrosis | 0.57291712 |
| 127 | MP0002090_abnormal_vision | 0.56372153 |
| 128 | MP0003632_abnormal_nervous_system | 0.56054740 |
| 129 | MP0003172_abnormal_lysosome_physiology | 0.54731205 |
| 130 | MP0002653_abnormal_ependyma_morphology | 0.54088913 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 5.62634134 |
| 2 | Febrile seizures (HP:0002373) | 4.47005735 |
| 3 | Myokymia (HP:0002411) | 4.38229038 |
| 4 | Congenital stationary night blindness (HP:0007642) | 4.34290110 |
| 5 | Progressive cerebellar ataxia (HP:0002073) | 4.26734516 |
| 6 | Focal seizures (HP:0007359) | 4.19438681 |
| 7 | Epileptic encephalopathy (HP:0200134) | 4.02902245 |
| 8 | True hermaphroditism (HP:0010459) | 3.82104892 |
| 9 | Pancreatic cysts (HP:0001737) | 3.74497261 |
| 10 | Pancreatic fibrosis (HP:0100732) | 3.70450567 |
| 11 | Increased circulating renin level (HP:0000848) | 3.59156053 |
| 12 | Bony spicule pigmentary retinopathy (HP:0007737) | 3.49817125 |
| 13 | Visual hallucinations (HP:0002367) | 3.48745017 |
| 14 | Atonic seizures (HP:0010819) | 3.43151026 |
| 15 | Metabolic alkalosis (HP:0200114) | 3.41828096 |
| 16 | Action tremor (HP:0002345) | 3.39119065 |
| 17 | Central scotoma (HP:0000603) | 3.37348293 |
| 18 | Abnormality of macular pigmentation (HP:0008002) | 3.34888446 |
| 19 | Dyschromatopsia (HP:0007641) | 3.30677525 |
| 20 | Molar tooth sign on MRI (HP:0002419) | 3.22971587 |
| 21 | Abnormality of midbrain morphology (HP:0002418) | 3.22971587 |
| 22 | Genetic anticipation (HP:0003743) | 3.20195866 |
| 23 | Gaze-evoked nystagmus (HP:0000640) | 3.18367442 |
| 24 | Broad-based gait (HP:0002136) | 3.15758107 |
| 25 | Medial flaring of the eyebrow (HP:0010747) | 3.13856866 |
| 26 | Absence seizures (HP:0002121) | 3.09113768 |
| 27 | Nephronophthisis (HP:0000090) | 3.05395609 |
| 28 | Abnormal ciliary motility (HP:0012262) | 3.00623302 |
| 29 | Abnormal eating behavior (HP:0100738) | 2.94572666 |
| 30 | Generalized tonic-clonic seizures (HP:0002069) | 2.81636081 |
| 31 | Hypomagnesemia (HP:0002917) | 2.77162424 |
| 32 | Congenital primary aphakia (HP:0007707) | 2.76875049 |
| 33 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.75167962 |
| 34 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.74245407 |
| 35 | Hyperventilation (HP:0002883) | 2.72470083 |
| 36 | Genital tract atresia (HP:0001827) | 2.72312078 |
| 37 | Dialeptic seizures (HP:0011146) | 2.72238327 |
| 38 | Supranuclear gaze palsy (HP:0000605) | 2.71471057 |
| 39 | Abnormality of the renal medulla (HP:0100957) | 2.69565724 |
| 40 | Truncal ataxia (HP:0002078) | 2.68162865 |
| 41 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.67449257 |
| 42 | Dysdiadochokinesis (HP:0002075) | 2.67155298 |
| 43 | Intestinal atresia (HP:0011100) | 2.61372472 |
| 44 | Abolished electroretinogram (ERG) (HP:0000550) | 2.60487419 |
| 45 | Absent/shortened dynein arms (HP:0200106) | 2.57938014 |
| 46 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.57938014 |
| 47 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.57446436 |
| 48 | Vaginal atresia (HP:0000148) | 2.56860910 |
| 49 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.54860600 |
| 50 | Scotoma (HP:0000575) | 2.49042696 |
| 51 | Hypokalemic alkalosis (HP:0001949) | 2.46894296 |
| 52 | Urinary urgency (HP:0000012) | 2.44188366 |
| 53 | Dysmetria (HP:0001310) | 2.41901119 |
| 54 | Abnormality of the renal cortex (HP:0011035) | 2.41841665 |
| 55 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.41774643 |
| 56 | Impaired smooth pursuit (HP:0007772) | 2.40181852 |
| 57 | Hemiplegia (HP:0002301) | 2.39300263 |
| 58 | Decreased central vision (HP:0007663) | 2.38644075 |
| 59 | Scanning speech (HP:0002168) | 2.37756077 |
| 60 | Polydipsia (HP:0001959) | 2.37461936 |
| 61 | Abnormal drinking behavior (HP:0030082) | 2.37461936 |
| 62 | Abnormality of renin-angiotensin system (HP:0000847) | 2.36799946 |
| 63 | Abnormality of binocular vision (HP:0011514) | 2.36700229 |
| 64 | Diplopia (HP:0000651) | 2.36700229 |
| 65 | Lissencephaly (HP:0001339) | 2.32740928 |
| 66 | Abnormality of the labia minora (HP:0012880) | 2.32426392 |
| 67 | Polyuria (HP:0000103) | 2.31787117 |
| 68 | Hyperactive renin-angiotensin system (HP:0000841) | 2.31132488 |
| 69 | Type II lissencephaly (HP:0007260) | 2.30676398 |
| 70 | Keratoconus (HP:0000563) | 2.30266263 |
| 71 | Increased corneal curvature (HP:0100692) | 2.30266263 |
| 72 | Abnormality of the corticospinal tract (HP:0002492) | 2.29642993 |
| 73 | Excessive salivation (HP:0003781) | 2.29263941 |
| 74 | Drooling (HP:0002307) | 2.29263941 |
| 75 | Short tibia (HP:0005736) | 2.28330200 |
| 76 | Depression (HP:0000716) | 2.28022143 |
| 77 | Volvulus (HP:0002580) | 2.27607689 |
| 78 | Postaxial foot polydactyly (HP:0001830) | 2.27159137 |
| 79 | Cystic liver disease (HP:0006706) | 2.25850891 |
| 80 | Chronic hepatic failure (HP:0100626) | 2.25418928 |
| 81 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 2.25199650 |
| 82 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.24605436 |
| 83 | Ankle clonus (HP:0011448) | 2.24509081 |
| 84 | Optic nerve hypoplasia (HP:0000609) | 2.23679210 |
| 85 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.22623126 |
| 86 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.22623126 |
| 87 | Postural instability (HP:0002172) | 2.20821764 |
| 88 | Fetal akinesia sequence (HP:0001989) | 2.20068606 |
| 89 | Pendular nystagmus (HP:0012043) | 2.18975634 |
| 90 | Postaxial hand polydactyly (HP:0001162) | 2.18927759 |
| 91 | Abnormality of magnesium homeostasis (HP:0004921) | 2.18079464 |
| 92 | Oligodactyly (hands) (HP:0001180) | 2.17817885 |
| 93 | Attenuation of retinal blood vessels (HP:0007843) | 2.16062360 |
| 94 | Poor eye contact (HP:0000817) | 2.15025620 |
| 95 | Megalencephaly (HP:0001355) | 2.14975849 |
| 96 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.14559577 |
| 97 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 2.14360167 |
| 98 | Anencephaly (HP:0002323) | 2.12889094 |
| 99 | Tented upper lip vermilion (HP:0010804) | 2.11046404 |
| 100 | Renal cortical cysts (HP:0000803) | 2.10713321 |
| 101 | Sclerocornea (HP:0000647) | 2.10500764 |
| 102 | Pachygyria (HP:0001302) | 2.09460656 |
| 103 | Absent speech (HP:0001344) | 2.09121924 |
| 104 | Mutism (HP:0002300) | 2.07176989 |
| 105 | Septo-optic dysplasia (HP:0100842) | 2.06641480 |
| 106 | Hemiparesis (HP:0001269) | 2.06013056 |
| 107 | Abnormal urine output (HP:0012590) | 2.05262808 |
| 108 | Spastic gait (HP:0002064) | 2.05044481 |
| 109 | Specific learning disability (HP:0001328) | 2.04427670 |
| 110 | Agitation (HP:0000713) | 2.03733386 |
| 111 | Abnormality of chloride homeostasis (HP:0011422) | 2.03393226 |
| 112 | Impaired social interactions (HP:0000735) | 2.02482216 |
| 113 | Abnormal social behavior (HP:0012433) | 2.02482216 |
| 114 | Dysmetric saccades (HP:0000641) | 2.01919208 |
| 115 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.00807145 |
| 116 | Polyphagia (HP:0002591) | 1.99562950 |
| 117 | Hyperaldosteronism (HP:0000859) | 1.99325476 |
| 118 | Poor coordination (HP:0002370) | 1.98161546 |
| 119 | Gait imbalance (HP:0002141) | 1.97232773 |
| 120 | Inability to walk (HP:0002540) | 1.96230935 |
| 121 | Choroideremia (HP:0001139) | 1.95048530 |
| 122 | Congenital hepatic fibrosis (HP:0002612) | 1.93391795 |
| 123 | Anxiety (HP:0000739) | 1.93128889 |
| 124 | Renal hypoplasia (HP:0000089) | 1.92860693 |
| 125 | Horizontal nystagmus (HP:0000666) | 1.92078213 |
| 126 | Papilledema (HP:0001085) | 1.91901497 |
| 127 | Chorioretinal atrophy (HP:0000533) | 1.91523384 |
| 128 | Amblyopia (HP:0000646) | 1.91086697 |
| 129 | Abnormality of renal excretion (HP:0011036) | 1.86900498 |
| 130 | Cutaneous finger syndactyly (HP:0010554) | 1.86751220 |
| 131 | Status epilepticus (HP:0002133) | 1.86635628 |
| 132 | Cerebellar dysplasia (HP:0007033) | 1.86563449 |
| 133 | Progressive inability to walk (HP:0002505) | 1.86246093 |
| 134 | Gastrointestinal atresia (HP:0002589) | 1.85701142 |
| 135 | Photophobia (HP:0000613) | 1.83649435 |
| 136 | Intention tremor (HP:0002080) | 1.82693528 |
| 137 | Preaxial hand polydactyly (HP:0001177) | 1.82689244 |
| 138 | Short foot (HP:0001773) | 1.82535495 |
| 139 | Small hand (HP:0200055) | 1.82380148 |
| 140 | Epileptiform EEG discharges (HP:0011182) | 1.82346490 |
| 141 | Narrow forehead (HP:0000341) | 1.81821077 |
| 142 | Stereotypic behavior (HP:0000733) | 1.81318796 |
| 143 | Type II diabetes mellitus (HP:0005978) | 1.79519368 |
| 144 | Stomach cancer (HP:0012126) | 1.78637586 |
| 145 | Male pseudohermaphroditism (HP:0000037) | 1.78277881 |
| 146 | Morphological abnormality of the middle ear (HP:0008609) | 1.75845952 |
| 147 | Methylmalonic acidemia (HP:0002912) | 1.75753761 |
| 148 | Furrowed tongue (HP:0000221) | 1.75167666 |
| 149 | Severe visual impairment (HP:0001141) | 1.74421377 |
| 150 | Limb dystonia (HP:0002451) | 1.74166989 |
| 151 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 1.74155875 |
| 152 | EEG with generalized epileptiform discharges (HP:0011198) | 1.73726359 |
| 153 | Rhinitis (HP:0012384) | 1.72928477 |
| 154 | Protruding tongue (HP:0010808) | 1.72784302 |
| 155 | Nephrogenic diabetes insipidus (HP:0009806) | 1.72701523 |
| 156 | Short 4th metacarpal (HP:0010044) | 1.72637885 |
| 157 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 1.72637885 |
| 158 | Thyroiditis (HP:0100646) | 1.72206565 |
| 159 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 1.72192976 |
| 160 | Asplenia (HP:0001746) | 1.71980387 |
| 161 | Impaired vibratory sensation (HP:0002495) | 1.71215611 |
| 162 | Aplasia/Hypoplasia of the sternum (HP:0006714) | 1.70973451 |
| 163 | Broad foot (HP:0001769) | 1.69268937 |
| 164 | Large for gestational age (HP:0001520) | 1.67974964 |
| 165 | Dyskinesia (HP:0100660) | 1.64991158 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NTRK3 | 4.41483255 |
| 2 | FRK | 4.19668706 |
| 3 | MARK1 | 3.52628305 |
| 4 | MAP3K9 | 2.92849185 |
| 5 | MAP2K7 | 2.65981725 |
| 6 | MAP3K4 | 2.60800518 |
| 7 | NTRK2 | 2.51452790 |
| 8 | MAP4K2 | 2.44437383 |
| 9 | BMPR1B | 2.38571047 |
| 10 | CASK | 2.32920799 |
| 11 | EPHA4 | 2.25962411 |
| 12 | MINK1 | 2.13191105 |
| 13 | WNK3 | 2.12312096 |
| 14 | TNIK | 2.09438363 |
| 15 | PAK6 | 2.04263207 |
| 16 | ADRBK2 | 2.00154496 |
| 17 | ZAK | 1.96558243 |
| 18 | MAP3K13 | 1.95226562 |
| 19 | OXSR1 | 1.90917956 |
| 20 | STK38 | 1.88595848 |
| 21 | ERBB3 | 1.79301880 |
| 22 | SIK2 | 1.78791138 |
| 23 | BCR | 1.74730772 |
| 24 | PNCK | 1.70520711 |
| 25 | ACVR1B | 1.69797257 |
| 26 | TRIM28 | 1.66613724 |
| 27 | NUAK1 | 1.60233432 |
| 28 | MAP3K12 | 1.59513358 |
| 29 | SGK494 | 1.57447901 |
| 30 | SGK223 | 1.57447901 |
| 31 | PRPF4B | 1.55276521 |
| 32 | SGK2 | 1.55246151 |
| 33 | WNK4 | 1.52579264 |
| 34 | MAPK13 | 1.52151732 |
| 35 | WNK1 | 1.50933084 |
| 36 | MAP2K4 | 1.42454832 |
| 37 | CAMKK1 | 1.41695318 |
| 38 | DYRK2 | 1.39075472 |
| 39 | SGK3 | 1.34798062 |
| 40 | TNK2 | 1.34417930 |
| 41 | CDK5 | 1.34408271 |
| 42 | KSR1 | 1.33981696 |
| 43 | DAPK2 | 1.33519108 |
| 44 | PRKCH | 1.32467514 |
| 45 | TAOK3 | 1.29430720 |
| 46 | RIPK4 | 1.28428466 |
| 47 | GRK1 | 1.25193244 |
| 48 | CSNK1G1 | 1.22069183 |
| 49 | PRKD3 | 1.21489632 |
| 50 | PRKCG | 1.21311428 |
| 51 | TXK | 1.19990048 |
| 52 | NTRK1 | 1.18968965 |
| 53 | TLK1 | 1.17605584 |
| 54 | EPHA3 | 1.16958658 |
| 55 | NEK6 | 1.14940018 |
| 56 | CSNK1G3 | 1.13929177 |
| 57 | FES | 1.12592950 |
| 58 | CSNK1A1L | 1.10304488 |
| 59 | SIK3 | 1.07439160 |
| 60 | UHMK1 | 1.01771831 |
| 61 | STK11 | 0.99840426 |
| 62 | GRK5 | 0.95864074 |
| 63 | SGK1 | 0.95041779 |
| 64 | KSR2 | 0.91738991 |
| 65 | VRK1 | 0.90460150 |
| 66 | DYRK1A | 0.87166509 |
| 67 | MARK2 | 0.86891864 |
| 68 | FGFR2 | 0.85279160 |
| 69 | INSRR | 0.82845411 |
| 70 | CAMKK2 | 0.81207494 |
| 71 | CAMK1G | 0.80826041 |
| 72 | PLK2 | 0.80712613 |
| 73 | TYRO3 | 0.80653377 |
| 74 | MAP3K7 | 0.78469189 |
| 75 | MAPK15 | 0.76449977 |
| 76 | CAMK2A | 0.75033027 |
| 77 | DAPK1 | 0.74892089 |
| 78 | CAMK1 | 0.74566892 |
| 79 | WEE1 | 0.73539384 |
| 80 | CDC42BPA | 0.73481943 |
| 81 | DYRK3 | 0.68187423 |
| 82 | PINK1 | 0.68090799 |
| 83 | ALK | 0.67791508 |
| 84 | BMPR2 | 0.67118945 |
| 85 | PHKG2 | 0.66692550 |
| 86 | PHKG1 | 0.66692550 |
| 87 | TIE1 | 0.65313020 |
| 88 | STK39 | 0.64845309 |
| 89 | PKN1 | 0.64341159 |
| 90 | CDK19 | 0.63685881 |
| 91 | NLK | 0.62421477 |
| 92 | CSNK1G2 | 0.61760337 |
| 93 | PDK1 | 0.57835122 |
| 94 | CAMK2B | 0.57716073 |
| 95 | PAK3 | 0.57419992 |
| 96 | EPHB2 | 0.56993580 |
| 97 | RET | 0.56169104 |
| 98 | MAPK7 | 0.55719385 |
| 99 | PRKCZ | 0.54910248 |
| 100 | CDK18 | 0.53923103 |
| 101 | PLK4 | 0.53458326 |
| 102 | FYN | 0.53079158 |
| 103 | PRKCQ | 0.52749827 |
| 104 | ITK | 0.52188492 |
| 105 | PRKD2 | 0.52186881 |
| 106 | CDK15 | 0.52044875 |
| 107 | MKNK1 | 0.51555124 |
| 108 | RPS6KA3 | 0.50949768 |
| 109 | IRAK2 | 0.50479338 |
| 110 | HIPK2 | 0.49755925 |
| 111 | CSNK1A1 | 0.49507055 |
| 112 | CCNB1 | 0.49133810 |
| 113 | YES1 | 0.47452489 |
| 114 | ERBB2 | 0.46875602 |
| 115 | PTK2B | 0.46297047 |
| 116 | CAMK4 | 0.46251768 |
| 117 | MAPK10 | 0.46152088 |
| 118 | FER | 0.45832854 |
| 119 | CSNK1D | 0.45368488 |
| 120 | CDK14 | 0.45085797 |
| 121 | PRKCE | 0.45045510 |
| 122 | PRKACA | 0.44969851 |
| 123 | RPS6KA5 | 0.44936448 |
| 124 | CDK3 | 0.44598446 |
| 125 | PRKCB | 0.44434869 |
| 126 | CDK11A | 0.42861823 |
| 127 | MAP3K2 | 0.42356985 |
| 128 | MAPK12 | 0.41155180 |
| 129 | ROCK1 | 0.39148636 |
| 130 | STK38L | 0.38683203 |
| 131 | OBSCN | 0.38646509 |
| 132 | AKT3 | 0.37569424 |
| 133 | PLK3 | 0.37072582 |
| 134 | STK24 | 0.36253773 |
| 135 | TGFBR1 | 0.33209231 |
| 136 | PDPK1 | 0.33021032 |
| 137 | ADRBK1 | 0.32418503 |
| 138 | PRKG1 | 0.32345185 |
| 139 | LMTK2 | 0.31261883 |
| 140 | MKNK2 | 0.31173537 |
| 141 | EIF2AK3 | 0.29519014 |
| 142 | BRD4 | 0.29134696 |
| 143 | CAMK2D | 0.26623270 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phototransduction_Homo sapiens_hsa04744 | 3.65812268 |
| 2 | Nicotine addiction_Homo sapiens_hsa05033 | 3.53653019 |
| 3 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.91976966 |
| 4 | GABAergic synapse_Homo sapiens_hsa04727 | 2.45856872 |
| 5 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.39745552 |
| 6 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.37573701 |
| 7 | Morphine addiction_Homo sapiens_hsa05032 | 2.35896863 |
| 8 | Circadian entrainment_Homo sapiens_hsa04713 | 2.29264385 |
| 9 | Olfactory transduction_Homo sapiens_hsa04740 | 2.22573095 |
| 10 | Long-term potentiation_Homo sapiens_hsa04720 | 2.12169044 |
| 11 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.07150047 |
| 12 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.96084587 |
| 13 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.96057612 |
| 14 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.94678780 |
| 15 | Insulin secretion_Homo sapiens_hsa04911 | 1.92346369 |
| 16 | Salivary secretion_Homo sapiens_hsa04970 | 1.85153633 |
| 17 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.84086451 |
| 18 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.82124875 |
| 19 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.79290702 |
| 20 | Taste transduction_Homo sapiens_hsa04742 | 1.78859856 |
| 21 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.74982826 |
| 22 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.73716047 |
| 23 | Protein export_Homo sapiens_hsa03060 | 1.70922032 |
| 24 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.61546362 |
| 25 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.57913559 |
| 26 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.56464603 |
| 27 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.53839569 |
| 28 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.51526631 |
| 29 | Long-term depression_Homo sapiens_hsa04730 | 1.49810844 |
| 30 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.49379978 |
| 31 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.48660282 |
| 32 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.46302172 |
| 33 | Basal transcription factors_Homo sapiens_hsa03022 | 1.43100062 |
| 34 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.42326464 |
| 35 | Cocaine addiction_Homo sapiens_hsa05030 | 1.39688835 |
| 36 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.38946229 |
| 37 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.37157052 |
| 38 | Renin secretion_Homo sapiens_hsa04924 | 1.36446990 |
| 39 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.32798139 |
| 40 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.30245344 |
| 41 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.28330186 |
| 42 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.23690786 |
| 43 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.18139731 |
| 44 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.17008158 |
| 45 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.16927903 |
| 46 | Axon guidance_Homo sapiens_hsa04360 | 1.16381777 |
| 47 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.14376366 |
| 48 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.13714105 |
| 49 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.10663170 |
| 50 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.10623852 |
| 51 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.10277751 |
| 52 | * Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.08742275 |
| 53 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.05906395 |
| 54 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 1.04699275 |
| 55 | Basal cell carcinoma_Homo sapiens_hsa05217 | 1.02593626 |
| 56 | Gap junction_Homo sapiens_hsa04540 | 1.01982224 |
| 57 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.01950628 |
| 58 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.01473551 |
| 59 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.00286679 |
| 60 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.99826537 |
| 61 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.98724426 |
| 62 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.96768036 |
| 63 | Glioma_Homo sapiens_hsa05214 | 0.96740914 |
| 64 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.94921136 |
| 65 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.94594314 |
| 66 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.93310397 |
| 67 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.90204883 |
| 68 | * Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.89231527 |
| 69 | RNA degradation_Homo sapiens_hsa03018 | 0.88887882 |
| 70 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.87099759 |
| 71 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.86310836 |
| 72 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.84956812 |
| 73 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.84777713 |
| 74 | ABC transporters_Homo sapiens_hsa02010 | 0.84074995 |
| 75 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.82430336 |
| 76 | Melanogenesis_Homo sapiens_hsa04916 | 0.81653921 |
| 77 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.81468811 |
| 78 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.80457861 |
| 79 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.79635063 |
| 80 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.78775877 |
| 81 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.77529619 |
| 82 | Endometrial cancer_Homo sapiens_hsa05213 | 0.77263121 |
| 83 | Homologous recombination_Homo sapiens_hsa03440 | 0.75509104 |
| 84 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.75422720 |
| 85 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.74497797 |
| 86 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.74282487 |
| 87 | Peroxisome_Homo sapiens_hsa04146 | 0.74050963 |
| 88 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.73814641 |
| 89 | * Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.73772724 |
| 90 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.71746595 |
| 91 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.71564983 |
| 92 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.71532962 |
| 93 | Parkinsons disease_Homo sapiens_hsa05012 | 0.70814529 |
| 94 | Retinol metabolism_Homo sapiens_hsa00830 | 0.69933184 |
| 95 | Circadian rhythm_Homo sapiens_hsa04710 | 0.69434513 |
| 96 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.67488009 |
| 97 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.67381225 |
| 98 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.66645325 |
| 99 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.66489299 |
| 100 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.62261538 |
| 101 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.62138377 |
| 102 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.61612221 |
| 103 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.59010946 |
| 104 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.58164242 |
| 105 | Colorectal cancer_Homo sapiens_hsa05210 | 0.58153582 |
| 106 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.57549745 |
| 107 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.57504366 |
| 108 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.57282976 |
| 109 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.56843787 |
| 110 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.56632525 |
| 111 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.56274729 |
| 112 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.55966943 |
| 113 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.55844241 |
| 114 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.54585329 |
| 115 | Alzheimers disease_Homo sapiens_hsa05010 | 0.54424643 |
| 116 | RNA polymerase_Homo sapiens_hsa03020 | 0.54003876 |
| 117 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.52240491 |
| 118 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.52004431 |
| 119 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.51398116 |
| 120 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.51191702 |
| 121 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.50705461 |
| 122 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.48127474 |
| 123 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.47416618 |
| 124 | Huntingtons disease_Homo sapiens_hsa05016 | 0.46994519 |
| 125 | Mineral absorption_Homo sapiens_hsa04978 | 0.46377439 |
| 126 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.45666806 |
| 127 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.44874200 |
| 128 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.42958296 |
| 129 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.42737172 |
| 130 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.41738917 |
| 131 | Endocytosis_Homo sapiens_hsa04144 | 0.41711642 |
| 132 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.41515263 |
| 133 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.40624055 |
| 134 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.39960995 |
| 135 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.39366882 |
| 136 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.39173140 |
| 137 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.38966320 |
| 138 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.37802227 |
| 139 | Bile secretion_Homo sapiens_hsa04976 | 0.37110660 |
| 140 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.35249792 |
| 141 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.35142844 |
| 142 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.34841559 |
| 143 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.34710461 |
| 144 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.33519711 |
| 145 | Melanoma_Homo sapiens_hsa05218 | 0.32373509 |
| 146 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.31385632 |
| 147 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.31184722 |
| 148 | Alcoholism_Homo sapiens_hsa05034 | 0.30374685 |

